GR3025186T3 - The use of benzodiazepine compounds for preparing a pharmaceutical composition against CNS disorders related to the excitatory aminoacids - Google Patents
The use of benzodiazepine compounds for preparing a pharmaceutical composition against CNS disorders related to the excitatory aminoacidsInfo
- Publication number
- GR3025186T3 GR3025186T3 GR970402821T GR970402821T GR3025186T3 GR 3025186 T3 GR3025186 T3 GR 3025186T3 GR 970402821 T GR970402821 T GR 970402821T GR 970402821 T GR970402821 T GR 970402821T GR 3025186 T3 GR3025186 T3 GR 3025186T3
- Authority
- GR
- Greece
- Prior art keywords
- preparing
- pharmaceutical composition
- disorders related
- cns disorders
- composition against
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Fats And Perfumes (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US50928490A | 1990-04-13 | 1990-04-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
GR3025186T3 true GR3025186T3 (en) | 1998-02-27 |
Family
ID=24026006
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR970402821T GR3025186T3 (en) | 1990-04-13 | 1997-10-29 | The use of benzodiazepine compounds for preparing a pharmaceutical composition against CNS disorders related to the excitatory aminoacids |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0451626B1 (el) |
JP (1) | JP3015129B2 (el) |
AT (1) | ATE157873T1 (el) |
CA (1) | CA2040242A1 (el) |
DE (1) | DE69127572T2 (el) |
DK (1) | DK0451626T3 (el) |
ES (1) | ES2108017T3 (el) |
FI (1) | FI911784A (el) |
GR (1) | GR3025186T3 (el) |
IE (1) | IE910939A1 (el) |
NO (1) | NO911449L (el) |
PT (1) | PT97365B (el) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5317018A (en) * | 1992-06-09 | 1994-05-31 | Armin Walser | Benzodiazepines and compositions for treating anxiety and panic disorders, and idiopathic and psychomotor epilepsy |
CA2138533C (en) * | 1992-07-24 | 2009-04-14 | Gary S. Lynch | Drugs that enhance synaptic responses mediated by ampa receptors |
US5852008A (en) * | 1995-01-24 | 1998-12-22 | The Regents Of The University Of California | Heteroatom substituted benzoyl derivatives that enhance synaptic response mediated by receptors |
GB2346883B (en) * | 1996-09-02 | 2001-02-14 | Lilly Industries Ltd | GluR5 receptor binding assay |
KR102362725B1 (ko) * | 2018-10-22 | 2022-02-15 | (주)엘엑스하우시스 | 창호 시공용 낙하방지망 조립체 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MC1528A1 (fr) * | 1982-07-21 | 1984-04-13 | Hoffmann La Roche | Imidazobenzodiazepines |
CA1327008C (en) * | 1988-01-15 | 1994-02-15 | Walter Merz | Anti-psychotic imidazobenzodiazepine |
-
1991
- 1991-03-21 IE IE093991A patent/IE910939A1/en unknown
- 1991-03-27 DE DE69127572T patent/DE69127572T2/de not_active Expired - Fee Related
- 1991-03-27 ES ES91104888T patent/ES2108017T3/es not_active Expired - Lifetime
- 1991-03-27 DK DK91104888.2T patent/DK0451626T3/da active
- 1991-03-27 AT AT91104888T patent/ATE157873T1/de not_active IP Right Cessation
- 1991-03-27 EP EP91104888A patent/EP0451626B1/en not_active Expired - Lifetime
- 1991-04-11 CA CA002040242A patent/CA2040242A1/en not_active Abandoned
- 1991-04-12 PT PT97365A patent/PT97365B/pt not_active IP Right Cessation
- 1991-04-12 JP JP3079900A patent/JP3015129B2/ja not_active Expired - Fee Related
- 1991-04-12 NO NO91911449A patent/NO911449L/no unknown
- 1991-04-12 FI FI911784A patent/FI911784A/fi not_active Application Discontinuation
-
1997
- 1997-10-29 GR GR970402821T patent/GR3025186T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP0451626A2 (en) | 1991-10-16 |
IE910939A1 (en) | 1991-10-23 |
PT97365B (pt) | 1998-08-31 |
DK0451626T3 (da) | 1998-04-20 |
NO911449D0 (no) | 1991-04-12 |
DE69127572T2 (de) | 1998-01-22 |
NO911449L (no) | 1991-10-14 |
PT97365A (pt) | 1992-01-31 |
ES2108017T3 (es) | 1997-12-16 |
ATE157873T1 (de) | 1997-09-15 |
JPH04224516A (ja) | 1992-08-13 |
EP0451626A3 (en) | 1992-10-07 |
JP3015129B2 (ja) | 2000-03-06 |
EP0451626B1 (en) | 1997-09-10 |
DE69127572D1 (de) | 1997-10-16 |
CA2040242A1 (en) | 1991-10-14 |
FI911784A (fi) | 1991-10-14 |
FI911784A0 (fi) | 1991-04-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL95568A0 (en) | N-substituted-4-pyrimidinamines and pyrimidinidiamines,process for their preparation and pharmaceutical compositions containing them | |
IL107843A0 (en) | Aminomethylene substituted non-aromatic heterocycles | |
PH31123A (en) | Benzimidazole compounds. | |
HU9300898D0 (en) | Non-aromatic heterocyclic compounds containing condensed nitrogenb | |
EA200000592A1 (ru) | Азаполициклические соединения, конденсированные с арилом | |
IL106670A0 (en) | Substituted benzylamino nitrogen containing non-aromatic heterocycles | |
HUT62889A (en) | Process for producing benzoisothiazole and benzoisoxazole-3-carboxamide derivatives and pharmaceutical compositions comprising such compounds as active ingredient | |
NZ221543A (en) | 4-aminoquinoline derivatives and pharmaceutical compositions containing such | |
GR3025186T3 (en) | The use of benzodiazepine compounds for preparing a pharmaceutical composition against CNS disorders related to the excitatory aminoacids | |
YU5893A (sh) | Sulfonilkarbamid i postupak za njegovo dobijanje | |
PT85869A (en) | Process for preparing amino acid derivative anti-convulsant | |
IL104657A0 (en) | Benzazepine derivatives,their preparation and pharmaceutical compositions containing them | |
GR3015132T3 (en) | Novel ureas and thioureas, preparation thereof and application in therapy. | |
DE69827706D1 (de) | 5-(Heteroaryl)alkyl)-3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid (PBI) Derivate zur Behandlung von Störungen des zentralen Nervensystems |